KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Non Operating Income: 2010-2025

Historic Non Operating Income for TherapeuticsMD (TXMD) over the last 13 years, with Sep 2025 value amounting to $912,000.

  • TherapeuticsMD's Non Operating Income rose 60.85% to $912,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 34.81%. This contributed to the annual value of $2.4 million for FY2024, which is 209.48% up from last year.
  • As of Q3 2025, TherapeuticsMD's Non Operating Income stood at $912,000, which was down 26.45% from $1.2 million recorded in Q2 2025.
  • TherapeuticsMD's 5-year Non Operating Income high stood at $25.3 million for Q4 2021, and its period low was -$22.8 million during Q1 2022.
  • Its 3-year average for Non Operating Income is $468,909, with a median of $339,000 in 2023.
  • Data for TherapeuticsMD's Non Operating Income shows a peak YoY increase of 2,898.28% (in 2024) and a maximum YoY decrease of 2,385.19% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows TherapeuticsMD's Non Operating Income stood at $25.3 million in 2021, then plummeted by 99.96% to $11,000 in 2022, then skyrocketed by 145.45% to $27,000 in 2023, then tumbled by 2,385.19% to -$617,000 in 2024, then surged by 60.85% to $912,000 in 2025.
  • Its Non Operating Income stands at $912,000 for Q3 2025, versus $1.2 million for Q2 2025 and $203,000 for Q1 2025.